ID
42199
Descrição
Study of STA-1 as an Add-on Treatment to Donepezil; ODM derived from: https://clinicaltrials.gov/show/NCT01255046
Link
https://clinicaltrials.gov/show/NCT01255046
Palavras-chave
Versões (3)
- 30/08/2015 30/08/2015 -
- 13/04/2021 13/04/2021 - Dr. rer. medic Philipp Neuhaus
- 18/11/2021 18/11/2021 -
Transferido a
13 de abril de 2021
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Alzheimer Disease NCT01255046
Eligibility Alzheimer Disease NCT01255046
- StudyEvent: Eligibility
Descrição
Exclusion Criteria
Descrição
brain image (computed tomography (ct) scan or magnetic resonance imaging (mri) done within past 12 months prior to the study) and laboratory tests to exclude secondary dementia or non-alzheimer's dementia;
Tipo de dados
boolean
Alias
- UMLS CUI [1,1]
- C0024485
- UMLS CUI [1,2]
- C0040405
- UMLS CUI [1,3]
- C0587081
Descrição
patient with significant clinically central nervous system illness other than ad (e.g. parkinson's disease, human immunodeficiency virus (hiv) induced dementia, hachinski ischaemic score (his) >4) or dementia complicated by other organic disease or delirium;
Tipo de dados
boolean
Alias
- UMLS CUI [1]
- C0007682
Descrição
patient with a severe or uncontrolled diagnostic and statistical manual of mental disorders (dsm-iv) axis i disorder other than alzheimer's disease, including amnestic disorders, schizophrenia or schizoaffective disorder, bipolar disorder, current major depressive episode, psychosis, panic, or post-traumatic stress disorder;
Tipo de dados
boolean
Alias
- UMLS CUI [1]
- C0004936
Descrição
patient suffering from cerebral disturbances following a stroke or a cerebral trauma (if the event occurred within the last 6 months);
Tipo de dados
boolean
Alias
- UMLS CUI [1,1]
- C0038454
- UMLS CUI [1,2]
- C0234387
Descrição
patient with a history of hypersensitivity to study drugs;
Tipo de dados
boolean
Alias
- UMLS CUI [1]
- C0013182
Descrição
patient who has a history or evidence of a medical condition that would expose them to an undue risk of a significant adverse event or interfere with assessments of safety or efficacy during the course of the trial, including but not limited to hepatic, renal, respiratory, cardiovascular, endocrine (e.g., addison's disease), immune, neurologic, or hematologic disease as determined by the clinical judgment of the investigator;
Tipo de dados
boolean
Alias
- UMLS CUI [1]
- C3843040
Descrição
participation in any research study within the last 30 days;
Tipo de dados
boolean
Alias
- UMLS CUI [1]
- C0008976
Descrição
patient with significant alcohol or drug abuse as judged by the investigator.
Tipo de dados
boolean
Alias
- UMLS CUI [1]
- C0237123
Similar models
Eligibility Alzheimer Disease NCT01255046
- StudyEvent: Eligibility
CL386174 (UMLS CUI [2])
C0038454 (UMLS CUI [2])
C0677408 (UMLS CUI [2])
C0040405 (UMLS CUI [1,2])
C0587081 (UMLS CUI [1,3])
C0234387 (UMLS CUI [1,2])